HPV and Fluzone Can Be Administered Together
Yes, the HPV vaccine and Fluzone (influenza vaccine) can and should be given together at the same visit. Both vaccines are safe to administer simultaneously, and doing so increases the likelihood that patients will complete all recommended vaccinations on schedule.
Evidence Supporting Simultaneous Administration
The Advisory Committee on Immunization Practices (ACIP) explicitly states that quadrivalent HPV vaccine can be administered at the same visit as other age-appropriate vaccines, including influenza vaccines. 1
HPV vaccine is not a live vaccine and contains no components that adversely impact the safety or efficacy of other vaccinations, including influenza vaccines. 1
Each vaccine should be administered using a separate syringe at a different anatomic site (e.g., one in each deltoid muscle). 1
The ACIP emphasizes that administering all indicated vaccines together at a single visit increases the likelihood that adolescents and young adults will receive each vaccine on schedule. 1
Clinical Implementation
Both vaccines should be given intramuscularly, preferably in the deltoid muscle, using separate syringes and injection sites. 1
The standard HPV vaccine dose is 0.5 mL, while Fluzone formulations vary by product (e.g., Fluzone High-Dose Quadrivalent is 0.7 mL). 1, 2
There are no contraindications to simultaneous administration of HPV and influenza vaccines, provided neither vaccine has specific contraindications for the individual patient (such as severe allergic reaction to vaccine components). 1, 2
Addressing Missed Opportunities
Research demonstrates that missed opportunities for HPV vaccination are extremely common during visits where influenza vaccine is administered—occurring in approximately 57.5% of eligible visits. 3
Missed opportunities are particularly frequent during acute/chronic care visits and nurse-only visits (74.0% and 80.2% respectively) compared to preventive visits (36.7%). 3
Increasing simultaneous administration of HPV and influenza vaccines could substantially improve HPV vaccine coverage rates, which remain below national goals. 3
Common Pitfalls to Avoid
Do not delay HPV vaccination simply because the patient is receiving influenza vaccine—this represents a missed opportunity that contributes to suboptimal HPV coverage. 3
Do not assume that non-preventive visits (such as flu shot appointments) are inappropriate times to administer HPV vaccine if the patient is due for a dose. 3
Do not use the same syringe or injection site for both vaccines; each must be administered separately at different anatomic locations. 1
Do not withhold either vaccine based on unfounded safety concerns about simultaneous administration—the evidence strongly supports co-administration. 1
Age-Specific Considerations
For adolescents and young adults through age 26, HPV vaccination is routinely recommended and should be completed whenever the patient presents for any vaccine, including influenza. 4
The HPV vaccine schedule depends on age at initiation: those starting before age 15 require only 2 doses, while those starting at age 15 or older require 3 doses. 4
Fluzone High-Dose Quadrivalent is specifically indicated for adults ≥65 years of age, while standard Fluzone formulations are used in younger populations. 2, 5
budget:budget_used